Effect on ribonucleotide reductase of novel lipophilic iron chelators: The desferri-exochelins

Biochemical and Biophysical Research Communications

Volumn 315, Issue 3, 2004, Pages 595-598

  Hodges, Yvonne K ^a   Antholine, William E ^b   Horwitz, Lawrence D ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

DNA replication; Iron chelation; Ribonuceotide reductase

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE; DESFERRIEXOCHELIN; IRON CHELATE; RIBONUCLEOTIDE REDUCTASE; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DRUG DNA BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG SOLUBILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID SOLUBILITY; METAL BINDING; METAL EXTRACTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 1242295296     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.101     Document Type: Article

References (16)

1. Jordan A., Reichard P. Ribonucleotide reductases. Annu. Rev. Biochem. 67:1998;71-98.
2. Furukawa T., Naitoh Y., Kohno H., Tokunaga R., Taketani S. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis. Life Sci. 50:1992;2059-2065.
3. Gobin J., Moore C., Reeve J.R. Jr., Wong D., Gibson B., Horwitz M.A. Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins. Proc. Natl. Acad. Sci. USA. 92:1995;5189-51193.
4. Gobin J., Horwitz M.A. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J. Exp. Med. 183:1996;1527-1532.
5. Pahl P.M.B., Yan X.D., Hodges Y.K., Rosenthal E.A., Horwitz M.A., Horwitz L.D. An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro. J. Biol. Chem. 275:2000;17821-17826.
6. Pahl P.M.B., Horwitz M.A., Horwitz K.B., Horwitz L.D. Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res. Treat. 69:2001;69-79.
7. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416.
8. Baker E., Vitolo M.L., Webb J. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture. Biochem. Pharmcol. 34:1985;3011-3017.
9. Horwitz L.D., Sherman N.A., Kong Y., Pike A.W., Gobin J., Fennessey P.V., Horwitz M.A. Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc. Natl. Acad. Sci. USA. 95:1998;5263-5268.
10. Cooper C.E., Lynagh G.R., Hoyes K.P., Hider R.C., Cammack R., Porter J.B. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J. Biol. Chem. 271:1996;20291-20299.
11. Lloyd J.P., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmcol. 41:1991;1361-1363.
12. Hehlmann R., Berger U., Pfirrmann M., Hochhaus A., Metzgeroth G., Maywald O., Hasford J., Reiter A., Hossfeld D.K., Kolb H.J., Loffler H., Pralle H., Queisser W., Griesshammer M., Nerl C., Kuse R., Tobler A., Eimermacher H., Tichelli A., Aul C., Wilhelm M., Fischer J.T., Perker M., Scheid C., Schenk M., Weiss J., Meier C.R., Kremers S., Labedzki L., Schmeiser T., Lohrmann H.P., Heimpel H., Group G.C.-S. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. Leukemia. 17:2003;1529-1537.
13. Eklund H., Uhlin U., Farnegardh M., Logan D.T., Nordlund P. Structure and function of the radical enzyme ribonucleotide reductase. Prog. Biophys. Mol. Biol. 77(3):2001;177-268.
14. Wadler S., Zhang H., Cammer M., Hu X.P. Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system. Anal. Biochem. 267:1999;24-29.
15. Thelander L., Graslund A., Thelander M. Continual presence of oxygen and iron required for mammalian ribonucleotide reduction, possible regulation mechanism. Biochem. Biophys. Res. Commun. 110:1983;859-865.
16. Graslund A., Ehrenberg A., Thelander L. Characterization of the free radical of mammalian ribonucleotide reductase. J. Biol. Chem. 257:1982;5711-5715.